Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Didanosina")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 299

  • Page / 12
Export

Selection :

  • and

Longitudinal study on mitochondrial effects of didanosine-tenofovir combinationLOPEZ, Sonia; NEGREDO, Eugènia; CLOTET, Bonaventura et al.AIDS research and human retroviruses. 2006, Vol 22, Num 1, pp 33-39, issn 0889-2229, 7 p.Article

Immunological and virological effects of structured treatment interruptions following exposure to hydroxyurea plus didanosineBENITO, José Miguel; LOPEZ, Mariola; BALLESTEROS, Celia et al.AIDS research and human retroviruses. 2006, Vol 22, Num 8, pp 734-743, issn 0889-2229, 10 p.Article

Efficacy and Safety of Unboosted Atazanavir in Combination with Lamivudine and Didanosine in Naive HIV Type 1 Patients in SenegalLANDMAN, R; DIALLO, M. B; GIRARD, P. M et al.AIDS research and human retroviruses. 2010, Vol 26, Num 5, pp 519-525, issn 0889-2229, 7 p.Article

Didanosine in HIV-1-infected patients experiencing failure of antiretroviral therapy : A randomized placebo-controlled trialMOLINA, Jean-Michel; MARCELIN, Anne-Geneviève; PAVIE, Juliette et al.The Journal of infectious diseases. 2005, Vol 191, Num 6, pp 840-847, issn 0022-1899, 8 p.Article

A proof-of-concept study of short-cycle intermittent antiretroviral therapy with a once-daily regimen of didanosine, lamivudine, and efavirenz for the treatment of chronic HIV infectionDYBUL, Mark; NIES-KRASKE, Elizabeth; METCALF, Julia A et al.The Journal of infectious diseases. 2004, Vol 189, Num 11, pp 1974-1982, issn 0022-1899, 9 p.Article

Activity, safety, and immunological effects of hydroxyurea added to didanosine in antiretroviral-naive and experienced HIV type 1-infected subjects: A randomized, placebo-controlled trial, ACTG 307FRANK, Ian; BOSCH, Ronald J; FOX, Lawrence et al.AIDS research and human retroviruses. 2004, Vol 20, Num 9, pp 916-926, issn 0889-2229, 11 p.Article

Pharmacokinetics of coadministered ritonavir-boosted elvitegravir and zidovudine, didanosine, stavudine, or abacavirRAMANATHAN, Srinivasan; GONG SHEN; HINKLE, John et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 46, Num 2, pp 160-166, issn 1525-4135, 7 p.Article

DidanosineLa Revue Prescrire. 2000, Vol 20, Num 209, issn 0247-7750, p. 587Article

Amino Acid Esters Substituted Phosphorylated Emtricitabine and Didanosine Derivatives as Antiviral and Anticancer AgentsKURUVA CHANDRA SEKHAR; JANARDHAN, Avilala; YELLAPU NANDA KUMAR et al.Applied biochemistry and biotechnology. 2014, Vol 173, Num 6, pp 1303-1318, issn 0273-2289, 16 p.Article

Frequency and nature of drug-drug interactions in the intensive care unitASKARI, Marjan; ESLAMI, Saied; LOUWS, Mathijs et al.Pharmacoepidemiology and drug safety. 2013, Vol 22, Num 4, pp 430-437, issn 1053-8569, 8 p.Article

The value of screening HIV-infected individuals for didanosine-related liver disease?SCOURFIELD, Andrew; JACKSON, Akil; WATERS, Laura et al.Antiviral therapy (London). 2011, Vol 16, Num 6, pp 941-942, issn 1359-6535, 2 p.Article

Intracellular Nucleotide Levels during Coadministration of Tenofovir Disoproxil Fumarate and Didanosine in HIV-1-Infected PatientsHAWKINS, Trevor; VEIKLEY, Wenoah; DURAND-GASSELIN, Lucie et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 4, pp 1549-1555, issn 0066-4804, 7 p.Article

The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIVSCHIANO, Thomas D; URIEL, Alison; DIETERICH, Douglas T et al.Virchows Archiv. 2011, Vol 458, Num 2, pp 231-235, issn 0945-6317, 5 p.Article

Abacavir, didanosine and tenofovir do not induce inflammatory, apoptotic or oxidative stress genes in coronary endothelial cellsKIM, Chul; GUPTA, Samir K; GREEN, Linden et al.Antiviral therapy (London). 2011, Vol 16, Num 8, pp 1335-1339, issn 1359-6535, 5 p.Article

Didanosine Polymorphism in a Supercritical Antisolvent ProcessBETTINI, R; MENABENI, R; TOZZI, R et al.Journal of pharmaceutical sciences. 2010, Vol 99, Num 4, pp 1855-1870, issn 0022-3549, 16 p.Article

Didanosine: hypertensions portales non cirrhotiques = Serious liver disorders associated with the use of didanosineLa Revue Prescrire. 2010, Vol 30, Num 319, issn 0247-7750, p. 348Article

Didanosine ester prodrugs: Synthesis, albumin binding properties and pharmacokinetic studies in ratsHØYEM, Sverre; BRUHEIM, Skjalg; MAELANDSMO, Gunhild et al.European journal of medicinal chemistry. 2009, Vol 44, Num 10, pp 3874-3879, issn 0223-5234, 6 p.Article

The intestinal permeation of didanosine from granules containing microspheres using the everted gut sac modelFERREIRA DA SILVA, Classius; SEVERINO, Patricia; MARTINS, Fernanda et al.Journal of microencapsulation. 2009, Vol 26, Num 6, pp 523-528, issn 0265-2048, 6 p.Article

Application of thermal analysis to the study of lipidic prodrug incorporation into nanocarriersBOURGEOIS, Jennifer; PIERSON, Laure-Anne; NICOLAS, Julien et al.Journal of thermal analysis and calorimetry. 2009, Vol 98, Num 1, pp 65-71, issn 1388-6150, 7 p.Article

Incidence of cancer in children perinatally exposed to nucleoside reverse transcriptase inhibitorsBENHAMMOU, Valérie; WARSZAWSKI, Josiane; CLAVEL, Jacqueline et al.AIDS (London). 2008, Vol 22, Num 16, pp 2165-2177, issn 0269-9370, 13 p.Article

Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovirCRANE, Heidi M; KESTENBAUM, Bryan; HARRINGTON, Robert D et al.AIDS (London). 2007, Vol 21, Num 11, pp 1431-1439, issn 0269-9370, 9 p.Article

Comparison of cytochrome P450 inhibition assays for drug discovery using human liver microsomes with LC-MS, rhCYP450 isozymes with fluorescence, and double cocktail with LC-MSLI DI; KERNS, Edward H; LI, Susan Q et al.International journal of pharmaceutics. 2007, Vol 335, Num 1-2, pp 1-11, issn 0378-5173, 11 p.Article

Five-year follow up of once-daily therapy with emtricitabine, didanosine and efavirenz (Montana ANRS 091 trial)MOLINA, Jean-Michel; JOURNOT, Valérie; FURCO, André et al.Antiviral therapy (London). 2007, Vol 12, Num 3, pp 417-422, issn 1359-6535, 6 p.Article

Low-level K65R mutation in HIV-1 reverse transcriptase of treatment-experienced patients exposed to abacavir or didanosineSVAROVSKAIA, Evguenia S; MARGOT, Nicolas A; BAE, Andrew S et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 46, Num 2, pp 174-180, issn 1525-4135, 7 p.Article

Synthesis and biological evaluation of two glycerolipidic prodrugs of didanosine for direct lymphatic delivery against HIVLALANNE, Muriel; PACI, Angelo; ANDRIEUX, Karine et al.Bioorganic & medicinal chemistry letters (Print). 2007, Vol 17, Num 8, pp 2237-2240, issn 0960-894X, 4 p.Article

  • Page / 12